Ian M. Estepan
2021
In 2021, Ian M. Estepan earned a total compensation of $5.1M as Executive Vice President, Chief Financial Officer at Sarepta Therapeutics, a 1% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $315,000 |
|---|---|
| Option Awards | $2,959,290 |
| Salary | $525,000 |
| Stock Awards | $1,306,650 |
| Other | $21,745 |
| Total | $5,127,685 |
Estepan received $3M in option awards, accounting for 58% of the total pay in 2021.
Estepan also received $315K in non-equity incentive plan, $525K in salary, $1.3M in stock awards and $21.7K in other compensation.
Rankings
In 2021, Ian M. Estepan's compensation ranked 2,542nd out of 12,405 executives tracked by ExecPay. In other words, Estepan earned more than 79.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,542 out of 12,405 | 80th |
Division Manufacturing | 1,010 out of 5,494 | 82nd |
Major group Chemicals And Allied Products | 386 out of 2,369 | 84th |
Industry group Drugs | 337 out of 2,090 | 84th |
Industry Pharmaceutical Preparations | 221 out of 1,537 | 86th |
Pay ratio
| Ian M. Estepan's Pay | $5,127,685 |
|---|---|
| Median Employee's Pay | $271,908 |
| Pay Ratio | 19to 1 |
In 2021, the annual total compensation of Ian M. Estepan was $5,127,685.
The annual total compensation of the median employee at Sarepta Therapeutics was $271,908.
The ratio of Ian M. Estepan's pay to the pay of median employee was therefore 19 to one.
Source: SEC filing on April 25, 2022.
Estepan's colleagues
We found four more compensation records of executives who worked with Ian M. Estepan at Sarepta Therapeutics in 2021.